Posts with tag Life Sciences

Sort by Latest
Rebranding generics as branded medicines – CJEU issues new guidance
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with...
December 9, 2022
5 min read
Dialogue at EU level on the legalisation of recreational cannabis – the German Federal Government’s White Paper will not suffice
The Federal Government submits its White Paper on the legalisation of recreational cannabis to the...
December 1, 2022
11 min read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders....
November 22, 2022
8 min read
The Second Draft Patent Examination Guidelines on Patent Linkage Invalidation, PTE and PTA
TTThe second draft amendment to the Patent Examination Guidelines (the “
November 3, 2022
4 min read
Update on the UK’s future medical device regulations: Extended timelines
The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) has recently announced the introduction...
October 31, 2022
2 min read
Blood, cells and tissues: regulatory change is coming
Approximately twenty years ago, the regulation of Substances of Human Origin (“SHO”)...
October 25, 2022
5 min read
Publication of the English version of the new French Clinical Trial Agreement templates
The French legislator recently updated the French clinical trial agreement template also called...
October 10, 2022
2 min read
The Activation of Payback on Medical Devices
The Italian Ministry of Health, in a Decree dated 6 July 2022, certified the overrun of the expenditure...
October 7, 2022
1 min read
The Pharmaceutical Intellectual Property and Competition Law Review
The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview...
September 16, 2022
1 min read
China’s First Supreme Court Patent Linkage Decision
On 5 August 2022, the Chinese Supreme Court (the “SPC”) handed down the second instance judgment on...
September 7, 2022
11 min read